z-logo
open-access-imgOpen Access
Treatment of Blood Cholesterol to Reduce Atheroscelerotic Cardiovascular Risk in Adults
Author(s) -
Cori Gray,
Craig Stern
Publication year - 2019
Publication title -
journal of contemporary pharmacy practice
Language(s) - English
Resource type - Journals
eISSN - 2573-2765
pISSN - 2573-2757
DOI - 10.37901/jcphp18-00004
Subject(s) - cholesterol , hyperlipidemia , medicine , blood lipids , endocrinology , familial hypercholesterolemia , high density lipoprotein , high cholesterol , lipoprotein , diabetes mellitus
Cholesterol is a fat-like substance our body needs to build cell membranes, make certain hormones and produce substances that aid in the digestion of fat. Two kinds of lipoproteins carry cholesterol throughout your body: low-density lipoproteins (LDL) and high-density lipoproteins (HDL). LDL cholesterol typically makes up 60–70 percent of the total serum cholesterol in our body and is the primary target of therapy. A high LDL level leads to a buildup of cholesterol in arteries.Hyperlipidemia occurs when your blood has too many lipids (or fats), such as cholesterol and triglycerides. Hypercholesterolemia means there is too much LDL (bad) cholesterol in your blood,3 and that increases your risk of developing atherosclerosis, coronary heart disease, stroke, and peripheral vascular disease.2 LDL-cholesterol levels of <100 mg/dL are considered optimal. At near optimal levels, 100–129 mg/dL, atherogenesis, the formation of abnormal fatty or lipid masses in arterial walls, occurs. At borderline high levels, 130–159 mg/dL, atherogenesis proceeds at a significant rate. At high levels, 160–189 mg/dL, and very high levels, ≥190 mg/dL, atherogenesis is accelerated.2Two main factors causing hyperlipidemia are lifestyle and genetic predispositions. An inherited condition called familial hypercholesterolemia (FH) causes very high LDL cholesterol.1

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom